Identification of Potential Urinary Metabolite Biomarkers of Pseudomonas aeruginosa Ventilator-Associated Pneumonia
暂无分享,去创建一个
H. Goossens | A. Covaci | P. Jorens | E. Fransen | G. Baggerman | S. Kumar-Singh | C. Lammens | S. Malhotra-Kumar | A. Hotterbeekx | J. Boddaert | B. Jongers | Kenny Bielen | P. Vervliet
[1] U. Argikar,et al. UDP-Glucuronosyltransferases , 2019, Handbook of Drug Metabolism.
[2] J. Rello,et al. Nosocomial pneumonia in 27 ICUs in Europe: perspectives from the EU-VAP/CAP study , 2016, European Journal of Clinical Microbiology & Infectious Diseases.
[3] P. Kubes,et al. Bispecific antibody targets multiple Pseudomonas aeruginosa evasion mechanisms in the lung vasculature , 2017, The Journal of clinical investigation.
[4] H. Vogel,et al. Plasma metabolomics for the diagnosis and prognosis of H1N1 influenza pneumonia , 2017, Critical Care.
[5] H. Goossens,et al. The endotracheal tube microbiome associated with Pseudomonas aeruginosa or Staphylococcus epidermidis , 2016, Scientific Reports.
[6] P. Jorens. Sticking to an Old Definition of Ventilator-Associated Pneumonia Is Not Old-Fashioned , 2016, Respiratory Care.
[7] J. Rello,et al. Pseudomonas aeruginosa ventilator-associated pneumonia management , 2016, Infection and drug resistance.
[8] P. Póvoa,et al. Incidence and prognosis of ventilator-associated tracheobronchitis (TAVeM): a multicentre, prospective, observational study. , 2015, The Lancet. Respiratory medicine.
[9] N. Singhal,et al. MALDI-TOF mass spectrometry: an emerging technology for microbial identification and diagnosis , 2015, Front. Microbiol..
[10] David S. Wishart,et al. MetaboAnalyst 3.0—making metabolomics more meaningful , 2015, Nucleic Acids Res..
[11] Wei Zhao,et al. A multifunctional bispecific antibody protects against Pseudomonas aeruginosa , 2014, Science Translational Medicine.
[12] M. Antonelli,et al. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients , 2013, Intensive Care Medicine.
[13] R. Vanholder,et al. A novel UPLC–MS–MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients , 2013, Analytical and Bioanalytical Chemistry.
[14] H. Vogel,et al. Gram-negative and Gram-Positive Bacterial Infections Give Rise to a Different Metabolic Response in a Mouse Model , 2012, Journal of proteome research.
[15] T. Welte,et al. Biomarkers in community-acquired pneumonia , 2012, Expert review of respiratory medicine.
[16] Jun Feng Xiao,et al. Metabolite identification and quantitation in LC-MS/MS-based metabolomics. , 2012, Trends in analytical chemistry : TRAC.
[17] Katharina Trunk,et al. The Opportunistic Pathogen Serratia marcescens Utilizes Type VI Secretion To Target Bacterial Competitors , 2011, Journal of bacteriology.
[18] A. Khanna,et al. Incidence, risk stratification, antibiogram of pathogens isolated and clinical outcome of ventilator associated pneumonia , 2011, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine.
[19] Albert J. Fornace,et al. Metabolomic Analysis in Severe Childhood Pneumonia in The Gambia, West Africa: Findings from a Pilot Study , 2010, PloS one.
[20] Sirish L. Shah,et al. Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile. , 2009, Journal of proteome research.
[21] T. Marrie,et al. Streptococcus pneumoniae and Staphylococcus aureus pneumonia induce distinct metabolic responses. , 2009, Journal of proteome research.
[22] T. M. O’Connell,et al. Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients , 2009, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[23] Gordon K. Smyth,et al. Testing significance relative to a fold-change threshold is a TREAT , 2009, Bioinform..
[24] J. Lindon,et al. Systems biology: Metabonomics , 2008, Nature.
[25] 古谷 良輔,et al. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.
[26] D. Klemp,et al. Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis , 2006, European Respiratory Journal.
[27] A. Prince,et al. Pathogen-host interactions in Pseudomonas aeruginosa pneumonia. , 2005, American journal of respiratory and critical care medicine.
[28] J. Rello,et al. Pneumonia in the intensive care unit , 2003, Critical care medicine.
[29] E. Martinez,et al. Rapid urinary antigen test for diagnosis of pneumococcal community-acquired pneumonia in adults , 2003, European Respiratory Journal.
[30] J. Timsit,et al. The significance of distal bronchial samples with commensals in ventilator-associated pneumonia: colonizer or pathogen? , 2002, Chest.
[31] M. Grisham,et al. Elevation of nitrotyrosine and nitrate concentrations in cystic fibrosis sputum , 2000, Pediatric pulmonology.
[32] G. Gilbert,et al. Rapid diagnosis of Legionella pneumophila serogroup 1 infection with the Binax enzyme immunoassay urinary antigen test , 1997, Journal of clinical microbiology.
[33] J. Bollag,et al. Microbial metabolism of pyridine, quinoline, acridine, and their derivatives under aerobic and anaerobic conditions , 1996 .
[34] R. Wunderink,et al. Ventilator-associated pneumonia due to Pseudomonas aeruginosa. , 1996, Chest.
[35] Leonard Leibovici,et al. Risk factors and a clinical index for diagnosis of Pseudomonas aeruginosa bacteremia. , 1995, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[36] D. M. Greenberg,et al. THE BACTERIAL METABOLISM OF L-HYDANTOIN-5-PROPIONIC ACID TO CARBAMYLGLUTAMIC ACID AND GLUTAMIC ACID. , 1963, The Journal of biological chemistry.
[37] A. Emwas,et al. The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research. , 2015, Methods in molecular biology.
[38] E. Want,et al. HILIC-UPLC-MS for exploratory urinary metabolic profiling in toxicological studies. , 2011, Analytical chemistry.
[39] N. Benowitz,et al. Nicotine chemistry, metabolism, kinetics and biomarkers. , 2009, Handbook of experimental pharmacology.
[40] M. Durán,et al. Quantitative gas chromatographic determination of urinary hydantoin-5-propionic acid in patients with disorders of folate/vitamin B12 metabolism. , 1986, Journal of chromatography.